Oral Oncology
Volume 38, Issue 4 , Pages 332-336 , June 2002

Tenascin and β6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas

  • Joseph A Regezi

      Affiliations

    • Department of Stomatology, 513 Parnassus, S-512, University of California, San Francisco, CA 94143-0424, USA
    • Department of Pathology, University of California, San Francisco California, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-415-476-8236; fax: +1-415-476-8236
    • ,
  • Daniel M Ramos

      Affiliations

    • Department of Stomatology, 513 Parnassus, S-512, University of California, San Francisco, CA 94143-0424, USA
    • ,
  • Robert Pytela

      Affiliations

    • Department of Medicine, University of California, California, USA
    • ,
  • Nusi P Dekker

      Affiliations

    • Department of Stomatology, 513 Parnassus, S-512, University of California, San Francisco, CA 94143-0424, USA
    • ,
  • Richard C.K Jordan

      Affiliations

    • Department of Stomatology, 513 Parnassus, S-512, University of California, San Francisco, CA 94143-0424, USA
    • Department of Pathology, University of California, San Francisco California, USA

Received 23 May 2001 ,Accepted 1 June 2001.

References 

  1. Speight PM, Morgan PR. The natural history and pathology of oral cancer and precancer. Comm Dent Health. 1993;10(Suppl.1):31–41
  2. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol. 1995;79:321–329
  3. Shafer WG. Oral carcinoma in situ. Oral Surg. 1975;39:227–238
  4. Shafer WG, Waldron CA. Erythroplakia of the oral cavity. Cancer. 1975;36:1021–1028
  5. Waldron CA, Shafer WG. Leukoplakia revisited. Cancer. 1975;36:1386–1392
  6. Kramer IRH, El-Labban N, Lee KW. The clinical features and risk of malignant transformation in sublingual keratosis. Brit Dent J. 1978;144:171–180
  7. Daley TD, Lovas JGL, Peters E, Wysocki GP, McGraw TW. Salivary gland duct involvement in oral epithelial dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol. 1996;812:186–192
  8. Hicks WL, Loree TR, Garcia RI, Maamoun S, Marshall D, Orner , et al.  Squamous cell carcinoma of the floor of the mouth: a 20 year review. Head Neck. 1997;19:400–405
  9. Teichgraeber JF, Clairmont AA. The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale. Head Neck Surg. 184;7:15–21
  10. Mighell AJ, Robinson PA, Hume WJ. Immunolocalization of tenascin-C in focal reactive overgrowths of oral mucosa. J Oral Pathol Med. 1996;25:163–169
  11. Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA. Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer. 1997;72:236–240
  12. Ramos DM, Chen BL, Boylen K, Stern M, Kramer R, Sheppard D, et al.  Stromal fibroblasts influence oral squamous cell carcinoma cell interactions with tenascin-C. Int J Cancer. 1997;72:369–376
  13. Ramos DM, Chen B, Regezi J, Zardi L, Pytela R. Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer. 1998;75:680–687
  14. Hindermann W, Berndt A, Borsi L, Luo X, Hyckel P, Katenkamp D, et al.  Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma. J Pathol. 1999;189:475–480
  15. Mori M, Muramatsu Y, Yamada K, Shrestha P, Takai Y. Intracellular localization of tenascin in squamous cell carcinoma of the oral cavity: an immunohistochemical study. Anticancer Research. 1996;16:3075–3080
  16. Harada T, Shinohara M, Nakamura S, Oka M. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Archiv. 1994;424:257–266
  17. Shrestha P, Sakamoto F, Takagi H, Yamada T, Mori M. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study. Oral Oncol, Eur J Cancer. 1994;30B:132–137
  18. Tiitta O, Happonen RP, Virtanen I, Luomanen M. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma. J Oral Pathol Med. 1994;23:446–450
  19. Breuss JM, Gallo J, Delisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, et al.  Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 1995;108:2241–2251
  20. Hamidi S, Salo T, Kainulainen T, Epstein J, Lerner K, Larjava H. Expression of αvβ6 integrin in oral leukoplakia. Br J Cancer. 2000;82:1433–1440
  21. Jones J, Watt FM, Speight PM. Changes in the expression of αv integrins in oral squamous cell carcinomas. J Oral Pathol. 1997;26:63–68
  22. Huang X, Wu J, Zhu W, Pytela R, Sheppard D. Expression of the human integrin beta6 subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in beta6 knockout mice. Am. J. Respir. Cell Mol. Biol. 1998;19:636–642
  23. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I, et al.  Tenascin in normal, reactive, hyperplastic, and neoplastic tissue: biologic and pathologic implications. Hum Pathol. 1991;22:636–643
  24. Chiquet-Ehrismann R, Mackie EJ, Pearson C, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interaction during fetal development and oncogenesis. Cell. 1986;47:131–139

PII: S1368-8375(01)00062-8

Oral Oncology
Volume 38, Issue 4 , Pages 332-336 , June 2002

Article Tools

* Image Usage & Resolution